ly3526318
Small moleculeexperimental
Clinical trial activity
7 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jun 21, 2019 (NCT03977974)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05580250 | Phase 1 | Nov 21, 2022 | Eli Lilly |
| NCT05177094 | Phase 2 | Jan 26, 2022 | Eli Lilly |
| NCT05086289 | Phase 2 | Nov 1, 2021 | Eli Lilly |
| NCT04682119 | Phase 1 | Dec 29, 2020 | Eli Lilly |
| NCT05986292 | Phase 2 | Jan 30, 2020 | Eli Lilly |
| NCT04183283 | Phase 1 | Dec 12, 2019 | Eli Lilly |
| NCT03977974 | Phase 1 | Jun 21, 2019 | Eli Lilly |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eli Lilly | For profit | 7 | 7 | 2 | 2019 |
1 organizations
Page 1 / 1